Skip to main content
. 2015 May 14;21(18):5685–5694. doi: 10.3748/wjg.v21.i18.5685

Table 1.

Clinical parameters of evaluable patients n (%)

Alequel (n = 14) Placebo (n = 15)
Sex (M:F) 6:8 6:9
Age (yr), mean (range) 35 (26-53) 30 (19-48)
Duration of disease, mean 9.1 7.4
Location of disease
Small bowel 8 6
Colon 5 3
Both 1 6
Steroid treatment 1 (7) 3 (20)
Thiopurine treatment 2 (14) 4 (27)
Baseline CDAI 303 (223-394) 281 (228-365)
Baseline IBDQ 142 151

M: Male; F: Female; CDAI: Crohn’s disease activity index; IBDQ: Inflammatory bowel disease questionnaire.